Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours

29 Jun 2017

Abstract excerpt

BACKGROUND: There is an urgent need for biomarkers for the early detection of ovarian cancer (OC). The purpose of this study was to assess whether changes in serum levels of lecithin-cholesterol acyltransferase (LCAT), sex hormone-binding globulin (SHBG), glucose-regulated protein, 78 kDa (GRP78), calprotectin and insulin-like growth factor-binding protein 2 (IGFBP2) are observed before clinical presentation and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Ferroptosis and cancer prognosis
Share to Ovarian cancer diagnosis and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28664912
DOI: 10.1038/bjc.2017.199

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumoursPMID 28664912Read ↗

Ovarian cancer risk prediction: a clinical epidemiology perspective.Semantic proximity Read ↗

Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategiesSemantic proximity Read ↗

Protein Z: A putative novel biomarker for early detection of ovarian cancerSemantic proximity Read ↗

Estimating the ovarian cancer CA-125 preclinical detectable phase, in-vivo tumour doubling time, and window for detection in early stage: an exploratory analysis of UKCTOCSSemantic proximity Read ↗

A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian CancerSemantic proximity Read ↗

Multi-analyte approach combining cfDNA sequencing and protein testing for early ovarian cancer detectionSemantic proximity Read ↗

An overview of biomarkers for the ovarian cancer diagnosis.Semantic proximity Read ↗

Multi-biomarker panel signature as the key to diagnosis of ovarian cancerSemantic proximity Read ↗

High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancerSemantic proximity Read ↗

An Immunohistochemical Algorithm for Ovarian Carcinoma Typing.Semantic proximity Read ↗

Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic profilingSemantic proximity Read ↗

Early prediction of ovarian cancer risk based on real world dataSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.